scholarly article | Q13442814 |
P50 | author | Adam Krętowski | Q24430625 |
Ewa Matyja | Q85632007 | ||
Magdalena Paczkowska-Abdulsalam | Q89862384 | ||
Magdalena Kaleta | Q114529429 | ||
Marta Perek-Polnik | Q47460874 | ||
Bożenna Dembowska-Bagińska | Q47460875 | ||
Joanna Trubicka | Q56839941 | ||
Bozena Cukrowska | Q57561055 | ||
Wiesława Grajkowska | Q57637804 | ||
Maria Lastowska | Q58656306 | ||
Monika Drogosiewicz | Q59671926 | ||
Magdalena Niemira | Q59672413 | ||
Agnieszka Karkucinska-Wieckowska | Q59708179 | ||
P2860 | cites work | Subgroup-specific structural variation across 1,000 medulloblastoma genomes | Q28271811 |
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies | Q28282708 | ||
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome | Q28298987 | ||
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features | Q33366431 | ||
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort | Q33764662 | ||
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours | Q35630417 | ||
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples | Q35837393 | ||
Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. | Q38374250 | ||
ALK Expression Is a Novel Marker for the WNT-activated Type of Pediatric Medulloblastoma and an Indicator of Good Prognosis for Patients | Q38879941 | ||
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays | Q43153279 | ||
Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma. | Q48162943 | ||
An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. | Q54427712 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | medulloblastoma | Q1333608 |
P304 | page(s) | 231-240 | |
P577 | publication date | 2018-02-09 | |
P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
P1476 | title | Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis | |
P478 | volume | 138 |
Q64065929 | A simplified approach using Taqman low-density array for medulloblastoma subgrouping |
Q93023273 | Association of Aggresomes with Survival Outcomes in Pediatric Medulloblastoma |
Q62492427 | MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma |
Q90270316 | Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma |
Q97525026 | Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes |
Q64087873 | Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas |
Search more.